Corient Capital Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$12.8M Hold
140,938
0.96% 15
2022
Q2
$12.8M Buy
140,938
+5,247
+4% +$478K 0.97% 16
2022
Q1
$11.1M Buy
135,691
+6,186
+5% +$508K 0.74% 23
2021
Q4
$9.93M Buy
129,505
+4,550
+4% +$349K 0.66% 29
2021
Q3
$9.39M Buy
124,955
+11,767
+10% +$884K 0.69% 27
2021
Q2
$8.8M Buy
113,188
+15,312
+16% +$1.19M 0.64% 29
2021
Q1
$7.2M Buy
97,876
+2,445
+3% +$180K 0.62% 34
2020
Q4
$7.45M Buy
95,431
+2,250
+2% +$176K 0.74% 28
2020
Q3
$7.38M Buy
93,181
+5,233
+6% +$414K 0.85% 20
2020
Q2
$6.49M Buy
87,948
+13,203
+18% +$974K 0.79% 27
2020
Q1
$5.49M Buy
74,745
+18,275
+32% +$1.34M 0.87% 25
2019
Q4
$4.9M Buy
56,470
+681
+1% +$59.1K 0.62% 33
2019
Q3
$4.48M Buy
55,789
+10,350
+23% +$831K 0.63% 35
2019
Q2
$3.64M Buy
45,439
+2,315
+5% +$185K 0.56% 39
2019
Q1
$3.42M Buy
43,124
+14,022
+48% +$1.11M 0.56% 36
2018
Q4
$2.12M Buy
29,102
+5,955
+26% +$434K 0.38% 67
2018
Q3
$1.57M Hold
23,147
0.26% 114
2018
Q2
$1.34M Buy
23,147
+3,383
+17% +$196K 0.23% 125
2018
Q1
$1.03M Sell
19,764
-3,592
-15% -$187K 0.19% 124
2017
Q4
$1.25M Sell
23,356
-1,519
-6% -$81.6K 0.21% 115
2017
Q3
$1.52M Sell
24,875
-2,867
-10% -$175K 0.29% 90
2017
Q2
$1.7M Buy
27,742
+369
+1% +$22.6K 0.26% 102
2017
Q1
$1.66M Buy
27,373
+218
+0.8% +$13.2K 0.26% 100
2016
Q4
$1.53M Sell
27,155
-544
-2% -$30.6K 0.27% 100
2016
Q3
$1.65M Buy
+27,699
New +$1.65M 0.31% 91